Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)). by Mobina Faqani (22783963)

“…<p>Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).…”

Phase 2 significant effects. by Wendy C. Crone (2262169)

“…<p>Graphical representations of eight significant effects observed between pre- and post-test means for intervention and control groups. …”

Phase 1 significant effects. by Wendy C. Crone (2262169)

Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease). by Mobina Faqani (22783963)

“…<p>Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease).…”

Phases of the intervention program. by Ana Beato (20489933)

Subjects:

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Subjects:

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Subjects:

Participant flow chart—Phase 1 (Baseline), Phase 2 (Intervention) and Phase 3 (Follow-up). by Kelly K. O’Brien (4954600)

Subjects:

Density plot showing the distribution of time in minutes of TTI, from NCCT imaging to significant intervention for both phases. by Justy Antony Chiramal (19207332)

Phase 2 of the FAST-M intervention study. by Sheikh Irfan Ahmed (15347962)

Demographic of study participants during the intervention phase (N = 106). by Le Duc Huy (12486817)

Subjects:

Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

Subjects:

Three Phases of Intervention Module Development (3P-IMD). by Rahmat Dapari (11326445)

Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

Subjects:

The three phases of intervention module development (3P-IMD). by Rahmat Dapari (11326445)

Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

Subjects:

Descriptive statistics of SRL phases concerning the two intervention groups, at the beginning and at the end of the intervention (values rounded to the second decimal place). by Janete Silva Moreira (18196201)

Average intake of porridge by the study groups during the intervention phase. by Janet Kajuju Malla (14059863)